Phase I Double Blind,Single & Multiple Ascending-Dose Study to Determine Effects of GDC-0134 in Patients w/ ALS
Clinical Trial Grant
Administered By
Ophthalmology, Glaucoma
Awarded By
Wake Research Associates, LLC
Start Date
March 28, 2017
End Date
December 31, 2020
Administered By
Ophthalmology, Glaucoma
Awarded By
Wake Research Associates, LLC
Start Date
March 28, 2017
End Date
December 31, 2020